| Literature DB >> 19914828 |
Nicholas Stock1, Christopher Baccei, Gretchen Bain, Alex Broadhead, Charles Chapman, Janice Darlington, Christopher King, Catherine Lee, Yiwei Li, Daniel S Lorrain, Pat Prodanovich, Haojing Rong, Angelina Santini, Jasmine Zunic, Jilly F Evans, John H Hutchinson, Peppi Prasit.
Abstract
A series of potent 5-lipoxygenase-activating protein (FLAP) inhibitors are herein described. SAR studies focused on the discovery of novel alicyclic moieties appended to an indole core to optimize potency, physical properties and off-target activities. Subsequent SAR on the N-benzyl substituent of the indole led to the discovery of compound 39 (AM679) which showed potent inhibition of leukotrienes in human blood and in a rodent bronchoalvelolar lavage (BAL) challenge model. Copyright 2009 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19914828 DOI: 10.1016/j.bmcl.2009.10.131
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823